Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Arthritis in United States

296 results

Sort By:

Exactech Shoulder Post Market Clinical Follow-up Study

Study ID: NCT05603728
Start Date: 2007-07-19
End Date: 2031-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20000

Intervention / Treatment
Sponsor

Exactech

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Study ID: NCT06869551
Start Date: 2025-03-13
End Date: 2031-03-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

60

Intervention / Treatment

Deucravacitinib

Placebo

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Study ID: NCT06991114
Start Date: 2025-07-09
End Date: 2029-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

Allogeneic NK Cells

Sponsor

Artiva Biotherapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Prospective Registry For Genicular Artery Embolization At The Joint & Vascular Institute

Study ID: NCT07380906
Start Date: 2025-07-16
End Date: 2030-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

Genicular Artery Embolization

Sponsor

Joint & Vascular Institute

Source: clinicaltrials.gov

Share:
Add to list

Psoriatic Arthritis D2P Screening

Study ID: NCT04110522
Start Date: 2019-07-22
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

18000

Intervention / Treatment

Direct to patient PsA Screening Questionnaire

Sponsor

Jessica Walsh

Source: clinicaltrials.gov

Share:
Add to list

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Study ID: NCT03816345
Start Date: 2019-07-16
End Date: 2028-03-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

300

Intervention / Treatment

Biospecimen Collection

Cabozantinib

Fluoropyrimidines

Ipilimumab

Nivolumab

Platinum Compound

Platinum Doublet

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Corticosteroid Injection Versus Nerve Block

Study ID: NCT06735027
Start Date: 2025-01-02
End Date: 2027-01-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

intraarticular corticosteroid injection (IACI)

suprascapular nerve block (SSNB)

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

MISHA Post-Market Clinical Study

Study ID: NCT06118892
Start Date: 2023-11-03
End Date: 2030-07-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

MISHA Knee System

Sponsor

Moximed

Source: clinicaltrials.gov

Share:
Add to list

Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

Study ID: NCT04275362
Start Date: 2017-02-02
End Date: 2029-01-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

102

Intervention / Treatment

DJO Empowr PS Knee System

Stryker Triathlon Total Knee System

Biomet Vanguard Complete Knee System

Control

Sponsor

More Foundation

Source: clinicaltrials.gov

Share:
Add to list

The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis

Study ID: NCT06911359
Start Date: 2025-03-31
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

Participants are given Ibuprofen 400 mg to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times.

Participants are given a placebo to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times.

Sponsor

David Grant U.S. Air Force Medical Center

Source: clinicaltrials.gov

Share:
Add to list